ReviewResearch in pharmaceutical sciences2025
Exploring cell dynamics and tumor microenvironments: a comprehensive review of decellularized extracellular matrix (dECM) scaffolds in breast and prostate cancer research.
Review in Research in pharmaceutical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Purpose: Decellularized extracellular matrix (dECM) scaffolds offer advanced platforms for studying breast and prostate cancer, enabling the replication of the tumor microenvironment (TME) with high fidelity. This review summarizes methodologies for creating dECM scaffolds, highlighting their biochemical and mechanical properties that enable up to 70% greater physiological relevance compared to traditional two-dimensional cultures. Search Strategy: A systematic literature search was conducted on PubMed, Scopus, and Web of Science databases (2010-2025) using keywords such as "decellularized extracellular matrix," "breast cancer," "prostate cancer," and "tumor microenvironment." Inclusion criteria focused on peer-reviewed studies employing dECM scaffolds in breast and prostate cancer research. Findings: Key findings reveal that dECM scaffolds effectively mimic tissue-specific TMEs, facilitating the study of tumor-stroma interactions, cellular responses, and drug resistance in breast and prostate cancers. dECM supports enhanced understanding of cancer progression mechanisms, including increased invasiveness, chemoresistance, and cell proliferation. Differences in decellularization methods influence ECM composition and scaffold function. Challenges, including standardization, clinical validation, and scalability, remain. Conclusion and Future Trends: dECM scaffolds hold great potential to advance cancer biology research and precision therapy development by providing biomimetic platforms. Future directions include integrating bioengineering advancements, AI-assisted ECM analysis, organoid and organ-on-chip models, and enhanced decellularization protocols to improve model fidelity and clinical relevance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.